Insider Transactions Reported by 19 Insiders of Opus Genetics, Inc.

Symbol
IRD on Nasdaq
Location
Durham, NC

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other* $11,808,167 -$8,600,000 -42% 09 Dec 2025
Cam Gallagher Director $4,708,956 +$323,693 +7.4% 06 Jan 2026
George Magrath Chief Executive Officer, Director $2,970,804 01 Nov 2025
Sean Ainsworth Director $674,927 01 Jan 2026
JAMES S. J. MANUSO Director $664,998 01 Jan 2026
BENJAMIN R. YERXA President, Director $622,059 22 Oct 2025
Jean Bennett Director $532,660 01 Jan 2026
Jay Pepose Director $318,508 11 Jun 2024
Ronil A. Patel Chief Business Officer $296,181 10 Jan 2024
Richard J. Rodgers Director $283,602 30 Apr 2025
Adrienne L. Graves Director $234,143 01 Jan 2026
Nirav S. Jhaveri Chief Financial Officer $223,437 13 Mar 2025
Bernhard Hoffmann SVP of Corp. Dev. $213,263 13 Mar 2025
Amy Rabourn Head of Fin. Quality Assurance $212,334 10 Jan 2026
Susan Benton Director $195,379 30 Apr 2025
Robert E. Gagnon Chief Financial Officer $192,000 02 Sep 2025
Mina Sooch President and CEO, Director $163,250 10 Jan 2023
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $144,678 13 Mar 2025
JOSEPH K. SCHACHLE Chief Operating Officer $62,675 13 Mar 2025

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.